Article
Presented by Mark S. Litwin, MD, University of California, Los Angeles.
FDA reports Urgent Field Safety Notice on mini PCNL sheath
Episode 1 Podcast: Understanding Overactive Bladder (OAB): Pathophysiology, Diagnosis, and Management in Older Adults
Investigators identify potential dual targets in prostate cancer
Former MLB player Dave Winfield shares lessons from baseball, philanthropy
FDA greenlights phase 1/2 trial of gene editing therapy for primary hyperoxaluria 1
NCCN reaffirms Prolaris’ prognostic value in prostate cancer